Valuation: Implantica AG

Market Cap 1.56B 1.8B 1.46B 1.34B 2.52B 171B 2.57B 17.2B 6.74B 85.45B 6.75B 6.6B 282B P/E 2026 *
-17.3x
P/E 2027 * -15x
Enterprise Value 1.54B 1.77B 1.43B 1.32B 2.48B 168B 2.52B 16.9B 6.62B 83.98B 6.64B 6.49B 277B EV / Sales 2026 *
430x
EV / Sales 2027 * 171x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
1 day+0.33%
1 week+4.64%
Current month-1.46%
1 month-5.58%
3 months+41.46%
6 months+25.44%
Current year+21.56%
1 week 57.7
Extreme 57.7
63
1 month 57.4
Extreme 57.4
69
Current year 38
Extreme 38
69
1 year 38
Extreme 38
82
3 years 16
Extreme 16
86.4
5 years 15.4
Extreme 15.4
136.8
10 years 15.4
Extreme 15.4
178.9
Manager TitleAgeSince
Chief Executive Officer 72 2014-12-31
Director of Finance/CFO 48 2019-12-31
Corporate Officer/Principal 69 -
Director TitleAgeSince
Chairman 67 2019-12-31
Director/Board Member 62 2019-12-31
Director/Board Member 71 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
9/24/25 Sell

Chief Financial Officer

16,700 0.0287%
9/24/25 Sell

Chief Financial Officer

17,100 0.0294%
9/24/25 Sell

Chief Financial Officer

29,500 0.0508%
Change 5-day change 1-year change 3-year change Capi.($)
+0.33%+4.64%-19.87%+202.23% 1.8B
+0.57%+1.10%+32.92%+26.54% 12.72B
+0.63%+2.59%+26.70%+23.71% 6.82B
+1.04%+0.73%+52.34%+26.93% 6.02B
+5.82%+8.09% - - 5.36B
-2.88%+5.86%-21.01%+40.05% 4.61B
+0.28%+4.30%-19.66%-17.76% 4.16B
+3.23%-10.04%+35.34%-47.35% 1.78B
+0.65%+0.49%+59.54%-4.33% 1.63B
+0.97%+5.22%-26.50%-49.99% 1.28B
Average +1.06%+1.68%+13.31%+22.23% 4.62B
Weighted average by Cap. +0.99%+2.43%+20.28%+24.01%

Financials

2026 *2027 *
Net sales 3.57M 4.11M 3.33M 3.06M 5.77M 391M 5.87M 39.29M 15.39M 195M 15.43M 15.09M 644M 9.14M 10.52M 8.54M 7.84M 14.78M 1B 15.04M 101M 39.43M 500M 39.52M 38.65M 1.65B
Net income -22.17M -25.51M -20.7M -19M -35.82M -2.43B -36.45M -244M -95.57M -1.21B -95.81M -93.68M -4B -25.65M -29.52M -23.95M -21.99M -41.46M -2.81B -42.18M -282M -111M -1.4B -111M -108M -4.63B
Net Debt -26.74M -30.77M -24.97M -22.92M -43.21M -2.93B -43.97M -294M -115M -1.46B -116M -113M -4.82B -308K -355K -288K -264K -498K -33.8M -507K -3.39M -1.33M -16.85M -1.33M -1.3M -55.59M
Logo Implantica AG
Implantica AG is Lichtenstein-based medical technology Company, whose mission is to provide effective treatment for serious health conditions and to improve patients' life through the use of advanced technologies in the human body, ultimately aiming to reduce costs and increase efficiency in the healthcare System. The therapies developed by Implantica are based on implants that are inserted into the patient's body and remain in the body permanently or semi-permanently to replace bodily functions and/or treat diseases. The Company focuses on the discovery, development and prospective commercialization of medical products and implants that are intended for use in different treatment fields like in the area of gastrointestinal surgery and urology. The Company's lead product is RefluxStop, a passive, implant to prevent gastroesophageal reflux disease (GERD).
Employees
-
Date Price Change Volume
26-08-04 SEK 60.90 +0.33% 23,114
26-08-03 SEK 60.70 -1.78% 23,452
26-07-31 SEK 61.80 +0.32% 19,940
26-07-30 SEK 61.60 +4.41% 10,571
26-07-29 SEK 59.00 +1.37% 27,247
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
5.514EUR
Average target price
6.725EUR
Spread / Average Target
+21.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IMP A SDB Stock